XENE

XENE R&D Expenses

$352.49MTTM · USD

Period ending:

XENE FY R&D ExpensesUSD
XENE FY R&D Expenses2011-12-31: $12.30M2012-12-31: $10.46M2013-12-31: $12.30M2014-12-31: $11.77M2015-12-31: $15.15M2016-12-31: $19.83M2017-12-31: $25.57M2018-12-31: $23.63M2019-12-31: $38.85M2020-12-31: $50.52M2021-12-31: $75.46M2022-12-31: $105.77M2023-12-31: $167.51M2024-12-31: $210.39M2025-12-31: $300.94M$300.94M$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XENE r&d expenses history

Research and development spending. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Xenon Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
300,938,000
210,394,000
167,512,000
105,767,000
75,463,000
50,523,000
38,845,000
23,634,000
25,573,000
19,828,000
15,152,000
11,768,000
12,303,000
10,455,000
12,302,000

Compare r&d expenses

All XENE financial metrics · XENE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.